Rhenman & Partners Asset Management AB as of June 30, 2017
Portfolio Holdings for Rhenman & Partners Asset Management AB
Rhenman & Partners Asset Management AB holds 108 positions in its portfolio as reported in the June 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Horizon Pharma | 4.1 | $29M | 2.4M | 11.87 | |
Exelixis (EXEL) | 3.7 | $26M | 1.1M | 24.63 | |
Novocure Ltd ord (NVCR) | 3.0 | $21M | 1.2M | 17.30 | |
Alexion Pharmaceuticals | 2.7 | $19M | 154k | 121.67 | |
Celgene Corporation | 2.6 | $18M | 142k | 129.87 | |
Gilead Sciences (GILD) | 2.6 | $18M | 257k | 70.78 | |
Incyte Corporation (INCY) | 2.5 | $18M | 140k | 125.91 | |
BioMarin Pharmaceutical (BMRN) | 2.5 | $17M | 189k | 90.82 | |
Medtronic (MDT) | 2.4 | $17M | 191k | 88.75 | |
Esperion Therapeutics (ESPR) | 2.4 | $17M | 363k | 46.28 | |
UnitedHealth (UNH) | 2.4 | $17M | 90k | 185.42 | |
Nektar Therapeutics (NKTR) | 2.2 | $16M | 795k | 19.55 | |
Abiomed | 2.2 | $15M | 106k | 143.30 | |
Pfizer (PFE) | 2.1 | $15M | 430k | 33.59 | |
Glaukos (GKOS) | 2.1 | $14M | 346k | 41.47 | |
Neuroderm Ltd F | 2.0 | $14M | 462k | 29.90 | |
Jazz Pharmaceuticals (JAZZ) | 1.9 | $13M | 85k | 155.50 | |
Biogen Idec (BIIB) | 1.9 | $13M | 49k | 271.36 | |
Allergan | 1.8 | $13M | 52k | 243.10 | |
Eli Lilly & Co. (LLY) | 1.8 | $12M | 150k | 82.30 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $12M | 95k | 128.87 | |
Zimmer Holdings (ZBH) | 1.7 | $12M | 90k | 128.40 | |
Nevro (NVRO) | 1.7 | $12M | 155k | 74.43 | |
Intra Cellular Therapies (ITCI) | 1.5 | $10M | 833k | 12.42 | |
Express Scripts Holding | 1.4 | $10M | 156k | 63.84 | |
Abbvie (ABBV) | 1.4 | $9.8M | 135k | 72.51 | |
Merck & Co (MRK) | 1.3 | $9.0M | 140k | 64.09 | |
Humana (HUM) | 1.2 | $8.4M | 35k | 240.63 | |
Hca Holdings (HCA) | 1.2 | $8.3M | 95k | 87.20 | |
Centene Corporation (CNC) | 1.1 | $8.0M | 100k | 79.88 | |
Alkermes (ALKS) | 1.1 | $7.8M | 135k | 57.97 | |
Walgreen Boots Alliance (WBA) | 1.1 | $7.8M | 100k | 78.31 | |
Sanofi-Aventis SA (SNY) | 1.1 | $7.7M | 160k | 47.91 | |
Dex (DXCM) | 1.1 | $7.6M | 104k | 73.15 | |
Endologix | 1.1 | $7.7M | 1.6M | 4.86 | |
CIGNA Corporation | 1.1 | $7.5M | 45k | 167.40 | |
Regeneron Pharmaceuticals (REGN) | 1.1 | $7.4M | 15k | 491.13 | |
CVS Caremark Corporation (CVS) | 1.0 | $6.8M | 85k | 80.46 | |
Alnylam Pharmaceuticals (ALNY) | 0.9 | $6.4M | 80k | 79.76 | |
Adamas Pharmaceuticals | 0.9 | $6.4M | 368k | 17.49 | |
Bristol Myers Squibb (BMY) | 0.9 | $6.3M | 114k | 55.72 | |
Livanova Plc Ord (LIVN) | 0.9 | $6.2M | 102k | 61.21 | |
Portola Pharmaceuticals | 0.9 | $6.2M | 111k | 56.17 | |
Kite Pharma | 0.9 | $6.2M | 60k | 103.67 | |
Universal Health Services (UHS) | 0.9 | $6.1M | 50k | 122.08 | |
Amgen (AMGN) | 0.9 | $6.0M | 35k | 172.23 | |
Revance Therapeutics (RVNC) | 0.8 | $5.8M | 220k | 26.40 | |
Aetna | 0.8 | $5.6M | 37k | 151.84 | |
Dynavax Technologies (DVAX) | 0.8 | $5.7M | 587k | 9.65 | |
Neurocrine Biosciences (NBIX) | 0.8 | $5.5M | 120k | 46.00 | |
Xencor (XNCR) | 0.8 | $5.5M | 260k | 21.11 | |
NxStage Medical | 0.8 | $5.4M | 214k | 25.07 | |
Fibrogen (FGEN) | 0.7 | $5.0M | 154k | 32.30 | |
Anthem (ELV) | 0.7 | $5.0M | 27k | 188.11 | |
Iovance Biotherapeutics (IOVA) | 0.7 | $4.8M | 650k | 7.35 | |
Immunomedics | 0.7 | $4.7M | 530k | 8.83 | |
Abbott Laboratories (ABT) | 0.7 | $4.6M | 95k | 48.61 | |
Thermo Fisher Scientific (TMO) | 0.6 | $4.4M | 25k | 174.48 | |
Cardinal Health (CAH) | 0.6 | $4.3M | 55k | 77.93 | |
AmerisourceBergen (COR) | 0.6 | $4.3M | 45k | 94.53 | |
Omnicell (OMCL) | 0.6 | $4.1M | 94k | 43.10 | |
Aerie Pharmaceuticals | 0.6 | $3.9M | 75k | 52.55 | |
Sage Therapeutics (SAGE) | 0.6 | $4.0M | 50k | 79.64 | |
Edwards Lifesciences (EW) | 0.6 | $3.9M | 33k | 118.24 | |
Epizyme | 0.6 | $3.8M | 252k | 15.10 | |
Rigel Pharmaceuticals | 0.5 | $3.8M | 1.4M | 2.73 | |
DaVita (DVA) | 0.5 | $3.6M | 55k | 64.76 | |
Array BioPharma | 0.5 | $3.6M | 425k | 8.37 | |
Radius Health | 0.5 | $3.4M | 75k | 45.23 | |
Hologic (HOLX) | 0.5 | $3.2M | 70k | 45.39 | |
Keryx Biopharmaceuticals | 0.4 | $3.1M | 425k | 7.23 | |
Laboratory Corp. of America Holdings | 0.4 | $3.1M | 20k | 154.15 | |
Macrogenics (MGNX) | 0.4 | $3.1M | 175k | 17.51 | |
Endo International | 0.4 | $3.1M | 277k | 11.17 | |
Coherus Biosciences (CHRS) | 0.3 | $2.4M | 169k | 14.35 | |
Ultragenyx Pharmaceutical (RARE) | 0.3 | $2.2M | 36k | 62.10 | |
Tetraphase Pharmaceuticals | 0.3 | $2.1M | 300k | 7.13 | |
Chimerix (CMRX) | 0.3 | $2.2M | 400k | 5.45 | |
Bioverativ Inc Com equity | 0.3 | $1.9M | 31k | 60.16 | |
Insulet Corporation (PODD) | 0.3 | $1.8M | 35k | 51.31 | |
Halozyme Therapeutics (HALO) | 0.2 | $1.5M | 120k | 12.82 | |
Supernus Pharmaceuticals (SUPN) | 0.2 | $1.3M | 30k | 43.10 | |
Rite Aid Corporation | 0.1 | $1.0M | 350k | 2.95 | |
ACADIA Pharmaceuticals (ACAD) | 0.1 | $837k | 30k | 27.90 | |
STAAR Surgical Company (STAA) | 0.1 | $755k | 70k | 10.79 | |
Achillion Pharmaceuticals | 0.1 | $762k | 166k | 4.59 | |
Forward Pharma A/s | 0.1 | $744k | 37k | 20.34 | |
Regulus Therapeutics | 0.1 | $588k | 594k | 0.99 | |
JPMorgan Chase & Co. (JPM) | 0.1 | $442k | 4.8k | 91.38 | |
Exxon Mobil Corporation (XOM) | 0.1 | $389k | 4.8k | 80.66 | |
Wells Fargo & Company (WFC) | 0.1 | $405k | 7.3k | 55.44 | |
Concert Pharmaceuticals I equity | 0.1 | $420k | 30k | 13.95 | |
Catabasis Pharmaceuticals | 0.1 | $441k | 311k | 1.42 | |
Adverum Biotechnologies | 0.1 | $385k | 154k | 2.50 | |
Microsoft Corporation (MSFT) | 0.1 | $330k | 4.8k | 68.85 | |
Halliburton Company (HAL) | 0.1 | $330k | 7.7k | 42.76 | |
Ford Motor Company (F) | 0.1 | $318k | 28k | 11.20 | |
Intercept Pharmaceuticals In | 0.1 | $364k | 3.0k | 121.01 | |
Ocular Therapeutix (OCUL) | 0.1 | $371k | 40k | 9.28 | |
Orexigen Therapeutics | 0.1 | $348k | 120k | 2.90 | |
International Business Machines (IBM) | 0.0 | $272k | 1.8k | 154.02 | |
Qualcomm (QCOM) | 0.0 | $296k | 5.4k | 55.14 | |
Anheuser-Busch InBev NV (BUD) | 0.0 | $310k | 2.8k | 110.48 | |
Mirati Therapeutics | 0.0 | $183k | 50k | 3.66 | |
Tandem Diabetes Care | 0.0 | $187k | 234k | 0.80 | |
Threshold Pharmaceuticals | 0.0 | $79k | 202k | 0.39 | |
Ophthotech | 0.0 | $61k | 24k | 2.55 | |
Anthera Pharmaceuticals (ANTH) | 0.0 | $41k | 25k | 1.64 |